News
Pfizer beats in Q2 earnings, reaffirms 2025 outlook
Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 billion in revenues. The company reported revenues of $14.7 billion, compared to Wall Street expectations of $13.5 billion, and earnings per share of $0.78, versus estimates of $0.58 per share.
Walt Disney posted better-than-expected results for April through June and raised its full-year earnings guidance on ...
Earnings jumped to $1.03 a share, up from $0.60 a year ago, as Emerson ( NYSE: EMR) improved its pretax margin by 570 basis ...
Fundraising stayed strong with $22 billion raised, and the quarterly dividend was held at $0.4375 per share. These 10 stocks could mint the next wave of millionaires › Brookfield Asset Management ...
Earnings per share is one of the best metrics of a company’s financial health. In this guide, Benzinga discusses the ins and outs of earnings per share (EPS).
Q2 2025 Management View Dave Cramer, President and CEO, reported sequential improvement in occupancy and contract rates, but ...
Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...
Nifty 50 EPS projected to grow by 10% in FY26, supported by fiscal measures and sectoral preferences, per Motilal Oswal.
23hon MSN
Q3 2025 Management View Stephen D. Westhoven, President and CEO, indicated, "Fiscal 2025 continues to be an excellent year ...
Analysts are estimating that PTC Therapeutics will report an earnings per share (EPS) of $-1.07. The announcement from PTC ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback